PFBT
LEGN icon

Parkside Financial Bank & Trust’s Legend Biotech LEGN Stock Holding History

Parkside Financial Bank & Trust’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23
Closed -$501 – 2749
2025
Q4 		$501 Hold
23
– – ﹤0.01% 2574
2025
Q3 		$751 Hold
23
– – ﹤0.01% 2390
2025
Q2 		$817 Buy
+23
New +$745 ﹤0.01% 2332

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.44B AUM 18.47% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Parkside Financial Bank & Trust's LEGN Position: Q1 2026 in Review

Parkside Financial Bank & Trust sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 23 shares — an estimated $501 sold.

Parkside Financial Bank & Trust first reported a position in LEGN in Q2 2025 and held it in 3 quarters. The position peaked at $817 in Q2 2025. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Parkside Financial Bank & Trust reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 23 Legend Biotech shares in Q1 2026, an estimated $501.
  • Parkside Financial Bank & Trust first reported a position in Legend Biotech in Q2 2025 and held it in 3 quarters.
  • Parkside Financial Bank & Trust's Legend Biotech position peaked at $817 in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.